Brief: Paratek Pharmaceuticals Announces Initiation Of Funding From Barda For Security Requirements And U.S. Onshoring Of The Manufacturing Supply Chain For Nuzyra
01/04/2020 13:11
April 1 (Reuters) - Paratek Pharmaceuticals Inc PRTK.O :
* PARATEK PHARMACEUTICALS ANNOUNCES INITIATION OF FUNDING
FROM
BARDA FOR SECURITY REQUIREMENTS AND U.S. ONSHORING OF THE
MANUFACTURING SUPPLY CHAIN FOR NUZYRA• (OMADACYCLINE)
* PARATEK PHARMACEUTICALS INC - REIMBURSEMENT COST FOR
ONSHORING
AND SECURITY REQUIREMENT ACTIVITIES IS PROJECTED TO TOTAL
APPROXIMATELY $20 MILLION
Source text for Eikon: ID:nGNX2Bq2yL
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million